BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yin H, Tang Y, Guo Y, Wen S. Immune Microenvironment of Thyroid Cancer. J Cancer 2020;11:4884-96. [PMID: 32626535 DOI: 10.7150/jca.44506] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Georgantzoglou N, Kokkali S, Tsourouflis G, Theocharis S. Tumor Microenvironment in Adrenocortical Carcinoma: Barrier to Immunotherapy Success? Cancers (Basel) 2021;13:1798. [PMID: 33918733 DOI: 10.3390/cancers13081798] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Xia Y, Jiang X, Huang Y, Liu Q, Huang Y, Zhang B, Mei Z, Xu D, Shi Y, Tu W. Construction of a Tumor Immune Microenvironment-Related Prognostic Model in BRAF-Mutated Papillary Thyroid Cancer. Front Endocrinol (Lausanne) 2022;13:895428. [PMID: 35757399 DOI: 10.3389/fendo.2022.895428] [Reference Citation Analysis]
3 Guo WP, Tang D, Pang YY, Li XJ, Chen G, Huang ZG, Tang XZ, Lai QQ, Gan JY, Huang XL, Liu XF, Wei ZX, Ma W. Immunohistochemical basigin expression level in thyroid cancer tissues. World J Surg Oncol 2020;18:240. [PMID: 32891152 DOI: 10.1186/s12957-020-01975-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Wu M, Wei B, Duan S, Liu M, Ou-yang D, Huang P, Chang S. Methylation-Driven Gene PLAU as a Potential Prognostic Marker for Differential Thyroid Carcinoma. Front Cell Dev Biol 2022;10:819484. [DOI: 10.3389/fcell.2022.819484] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Grassi ES, Ghiandai V, Persani L. Thyroid Cancer Stem-Like Cells: From Microenvironmental Niches to Therapeutic Strategies. J Clin Med 2021;10:1455. [PMID: 33916320 DOI: 10.3390/jcm10071455] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Yang M, Yin Y, Zhang J, Yi W, Liu J, Chen D, Zhang H, Fan X, Zhang Y, Zhu M, Qin S, Lv Z, Yu F. Cytokines: Application in recurrence appraisal for differentiated thyroid carcinoma and their relation with radioiodine ablation. J Cell Biochem 2021. [PMID: 34143519 DOI: 10.1002/jcb.30016] [Reference Citation Analysis]
7 Román-gil MS, Pozas J, Rosero-rodríguez D, Chamorro-pérez J, Ruiz-granados Á, Caracuel IR, Grande E, Molina-cerrillo J, Alonso-gordoa T. Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies. Cancer Treatment Reviews 2022;105:102372. [DOI: 10.1016/j.ctrv.2022.102372] [Reference Citation Analysis]
8 Gong J, Jin B, Shang L, Liu N. Characterization of the Immune Cell Infiltration Landscape of Thyroid Cancer for Improved Immunotherapy. Front Mol Biosci 2021;8:714053. [PMID: 34790698 DOI: 10.3389/fmolb.2021.714053] [Reference Citation Analysis]
9 Kapoor-Narula U, Lenka N. Cancer stem cells and tumor heterogeneity: Deciphering the role in tumor progression and metastasis. Cytokine 2022;157:155968. [PMID: 35872504 DOI: 10.1016/j.cyto.2022.155968] [Reference Citation Analysis]
10 Lorusso L, Cappagli V, Valerio L, Giani C, Viola D, Puleo L, Gambale C, Minaldi E, Campopiano MC, Matrone A, Bottici V, Agate L, Molinaro E, Elisei R. Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities. Int J Mol Sci 2021;22:3117. [PMID: 33803747 DOI: 10.3390/ijms22063117] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
11 Tarabichi M, Demetter P, Craciun L, Maenhaut C, Detours V. Thyroid cancer under the scope of emerging technologies. Mol Cell Endocrinol 2021;541:111491. [PMID: 34740746 DOI: 10.1016/j.mce.2021.111491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]